CardieX Limited (ASX:CDX)

Market Cap	20.67M
Revenue (ttm)	5.72M
Net Income (ttm)	-14.55M
Shares Out	405.23M
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	260,443
Average Volume	150,878
Open	0.0470
Previous Close	0.0460
Day's Range	0.0470 - 0.0530
52-Week Range	0.0450 - 0.1750
Beta	1.19
RSI	28.50
Earnings Date	May 29, 2025

About CardieX

CardieX Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffness indices. The company also provides medical devices and vascular biomarkers for hypertension, cardiovascular disease, and other vascular health disorders; an...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1994
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CDX

Financial Performance

In 2024, CardieX's revenue was 12.81 million, an increase of 125.14% compared to the previous year's 5.69 million. Losses were -6.77 million, -64.18% less than in 2023.